Work

PS3-2 Brexucabtagene autoleucel in relapsed/refractory mantle cell lymphoma (R/R MCL) in ZUMA-2: Durable responder analysis

Year: 2023

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2023.09.108

Authors: Javier Munoz, Patrick M. Reagan, Andre Goy, David B. Miklos, Dan Zheng, Xiang Fang, Rhine R. Shen, Rubina Siddiqi, Ioana Kloos, Marie José Kersten, Michael Wang

Institutions: Banner MD Anderson Cancer Center, University of Rochester Medicine, University of Rochester, Hackensack University Medical Center, Stanford Medicine, Stanford University, Kite (United States), Amsterdam University Medical Centers, University of Amsterdam, The University of Texas MD Anderson Cancer Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4388673575

FWCI:

Cites:

Cited by:

Related to: 10